Results 1 to 10 of about 62,886 (320)
What Affects the Quality of Pharmacovigilance? Insights From Qualitative Comparative Analysis [PDF]
Pharmacovigilance plays a significant role in guaranteeing the safety of medications for patients. Over the last three decades, China has significantly advanced its pharmacovigilance practices, yet the factors that drive the quality of pharmacovigilance ...
Yadong Wang+6 more
doaj +2 more sources
A comparative analysis of three pharmacovigilance system assessment tools. [PDF]
BackgroundThree key tools are currently available for assessing pharmacovigilance systems at the national level: the Indicator-Based Pharmacovigilance Assessment Tool (IPAT), the World Health Organization (WHO) Pharmacovigilance Indicators, and the ...
Muhammad Akhtar Abbas Khan+3 more
doaj +2 more sources
Pharmacovigilance-related events, disease burden and overall efficiency of care in european countries, 1990-2021 [PDF]
ObjectivesThis study aimed to evaluate and compare the disease burden of pharmacovigilance-related events in European countries, to identify the factors related to pharmacovigilance-related inputs in various countries, and to analyze and compare the ...
Lin Yin+15 more
doaj +2 more sources
Organisation of the Russian Pharmacovigilance System: Survey of Pharmacovigilance Officers
Ensuring the safety of pharmacotherapy is a priority of the national regulatory health policy and is enshrined in the international and federal legislation.
A. E. Krasheninnikov+2 more
doaj +1 more source
Research Progress of Antitumor Pharmacovigilance
In 2019, Drug Administration Law of China was first time proposed that the country should establish pharmacovigilance system. In 2021, the first Pharmacovigilance Quality Management Standard of China was released.
Wenjuan SUN, Yang HU, Yan XU, Bo ZHANG
doaj +1 more source
Audits and inspections of pharmacovigilance systems in Russia
The implementation of pharmacovigilance activities is impossible in isolation from compliance with the quality requirements of medicines and the activities of pharmaceutical and medical organizations throughout the pharmaceutical practice, as well as ...
A. A. Taube, B. K. Romanov
doaj +1 more source
Evaluation of Pharmacovigilance System in Iran [PDF]
BackgroundEvaluating a pharmacovigilance system helps identify its deficiencies and could facilitate measures to remedy and improve the quantity and quality of adverse drug reaction (ADR) reports and other opportunities for pharmacovigilance systems ...
Malahat Khalili+6 more
doaj +1 more source
Background Pharmacovigilance in China has experienced rapid development in the past 30 years. The implementation of Good Pharmacovigilance Practice in China since the end of 2021 heralds a new era of pharmacovigilance affairs, which puts forward higher ...
Yalan Tang+4 more
doaj +1 more source
BackgroundAlbeit the need for sex-disaggregated results of adverse events after immunization (AEFIs) is gaining attention since the COVID-19 pandemic, studies with emphasis on sexual dimorphism in response to COVID-19 vaccination are relatively scarce ...
Janneke W. Duijster+8 more
doaj +1 more source
Background Norovirus is an important cause of acute gastroenteritis globally. However, norovirus is rarely laboratory confirmed or recorded explicitly as a cause of hospitalization.
Elsa Negro Calduch+2 more
doaj +1 more source